| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
55 | 22 | 0 | 1,978 | 3,286 |
| Selling, General and Administrative Expenses
|
-22,971 | -23,428 | -23,510 | -34,868 | -37,633 |
|
Research and Development Expenses
|
-31,324 | -37,586 | -34,356 | -32,150 | -28,145 |
| Depreciation, Amortization and Depletion
|
-2,279 | -2,735 | -2,860 | -2,308 | -592 |
| Other Income/Expense, Operating
|
0 | -- | 0 | 583 | 1,000 |
|
Operating Income/Expenses
|
-56,574 | -63,749 | -60,726 | -68,743 | -65,370 |
|
Total Operating Profit/Loss
|
-56,519 | -63,727 | -60,726 | -66,765 | -62,084 |
| Total Net Finance Income/Expense
|
419 | 927 | 948 | 2,864 | 1,701 |
| Net Investment Income
|
0 | 0 | -12,725 | 3,960 | 0 |
|
Rental Income
|
3,200 | 5,423 | 6,449 | 2,323 | 0 |
| Irregular Income/Expenses
|
1,830 | -5,052 | -293 | -25,755 | 10,750 |
|
Other Income/Expense, Non-Operating
|
1,506 | 991 | 13,557 | -33 | -32 |
|
Non-Operating Income/Expenses, Total
|
6,955 | 2,289 | 7,936 | -16,641 | 12,419 |
|
Pretax Income
|
-49,564 | -61,438 | -52,790 | -83,406 | -49,665 |
|
Net Income from Continuing Operations
|
-49,564 | -61,438 | -52,790 | -83,406 | -49,665 |
|
Discontinued Operations
|
0 | -- | 0 | 12,348 | -8,545 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-49,564 | -61,438 | -52,790 | -71,058 | -58,210 |
|
Net Income after Non-Controlling/Minority Interests
|
-49,564 | -61,438 | -52,790 | -71,058 | -58,210 |
|
Net Income Available to Common Stockholders
|
-49,564 | -61,438 | -52,790 | -71,058 | -58,210 |
|
Diluted Net Income Available to Common Stockholders
|
-49,564 | -61,438 | -52,790 | -71,058 | -58,210 |
| Basic EPS
|
-1.77 | -2.73 | -12.03 | -16.01 | -22.30 |
| Diluted EPS
|
-1.77 | -2.73 | -12.03 | -16.01 | -22.30 |
|
Basic Weighted Average Shares Outstanding
|
28,966.9730 | 22,483.3910 | 4,595.9460 | 4,437.1060 | 2,611.0790 |
|
Diluted Weighted Average Shares Outstanding
|
28,966.9730 | 22,483.3910 | 4,595.9460 | 4,437.1060 | 2,611.0790 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-49,983 | -62,365 | -53,738 | -86,270 | -51,366 |
|
EBITDA
|
-46,831 | -58,728 | -49,900 | -80,841 | -47,446 |
|
Normalized EBITDA
|
-43,322 | -47,970 | -35,127 | -71,238 | -41,792 |
|
Normalized Income
|
-46,055 | -50,680 | -38,017 | -73,803 | -44,011 |
|
Total Unusual Items
|
3,509 | 10,758 | 14,773 | 9,603 | 5,654 |
12/31/2022 - 5/26/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade